Bell Potter Maintains IMMUTEP LTD(PRRUF.US) With Buy Rating, Cuts Target Price to $0.47
CCORF Maintains IMMUTEP LTD(PRRUF.US) With Buy Rating, Maintains Target Price $0.64
Analysts Offer Insights on Healthcare Companies: Immutep Ltd (OtherPRRUF) and Redcare Pharmacy (GB:0RJT)
Wilsons Sticks to Its Buy Rating for Immutep Ltd (PRRUF)
Immutep Ltd (PRRUF) Gets a Buy From Bell Potter
No Data
No Data